Global Health Sciences (GHS) Fund, Biosciences Managers, Kobuck, Relentless Venture Fund backed Canary Medical secured US $20M venture loan facility from Horizon Technology Finance Corporation and Silicon Valley Bank
Ripple Therapeutics secured licensing agreement with Théa Open Innovation (TOI) and $14.8M Series A tranche led by TOI with participation of BDC Capital and management. Colin Francou and François Lontrade from TOI/Laboratoires Théa will join Ripple Therapeutics board
PanTHERA CryoSolutions raised US $2M seed funding from BioLife Solutions and Casdin Capital. Dr. Aby J. Mathew of BioLife and Shaun Rodriguezof Casdin will join Dr. Robert Ben and Dr. Jason Acker on PanTHERA board.
DCVC Bio, Viking Global Investors, OrbiMed, Baker Brothers, Founders Fund, Eli Lilly backed AbCellera Biologics to raise up to US $391M (23M shares at US $14-17/share) from NASDAQ IPO. Dr. Carl L. G. Hansen’s stake worth up to US $1.04B